Global Viscosupplementation Injection Market Research Report 2021

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.
Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.
The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.
Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.
North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.
Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.

The global Viscosupplementation Injection market was valued at US$ 1139.9 million in 2020 and is expected to reach US$ 1586.5 million by the end of 2027, growing at a CAGR of 5.7% during 2021-2027.
This report focuses on Viscosupplementation Injection volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Viscosupplementation Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Viscosupplementation Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type
Single Injection
Three Injection
Five Injection


Segment by Application
Hospitals
Clinics
Others


By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng